On current fundamentals (up to latest reported FY25 numbers), both are very different propositions:

1. Business & Scale

- Uflex Ltd

- India’s largest integrated flexible packaging and packaging films MNC with plants in India and overseas; supplies to FMCG, food, pharma, etc., in 140+ countries. (uflexltd.com)

- FY25 consolidated revenue ~₹15,100–15,200 crore. (whatpackaging.co.in)

- RDB Rasayans Ltd

- Small-cap manufacturer of polymer-based woven sacks and FIBC (jumbo) bags; single main plant at Haldia, West Bengal; niche B2B packaging (bulk bags, liners). (icicidirect.com)

- FY25 revenue ~₹148 crore (three orders of magnitude smaller). (capitalmarket.com)

Merit: Uflex scores higher on size, diversification, and global presence; RDB Rasayans is a focused, niche micro-cap.

---

2. Profitability & Growth (FY25)

Uflex (consolidated)

- Revenue growth: ~12–13% YoY in FY25. (whatpackaging.co.in)

- PAT: turnaround from loss in FY24 to profit (~₹140–320 crore depending on normalised/ reported). PAT margin is low (~1–2.5%). (equitymaster.com)

- EBITDA margin: around 10–12%. (whatpackaging.co.in)

RDB Rasayans (standalone)

- Revenue: ₹148.4 crore in FY25 vs ₹103.2 crore in FY24 (≈44% growth). (capitalmarket.com)

- PAT: ₹26.5 crore vs ₹24.2 crore (≈9% growth); PAT margin ~17.8%. (capitalmarket.com)

- Operating/EBITDA margin: high double-digit (management commentary and ratios show ~20–25% type levels). (angelone.in)

Merit: On margins and profitability quality, RDB Rasayans is clearly superior (higher PAT margin and operating margin). Uflex is in turnaround; profitability is improving but still thin.

---

3. Balance Sheet & Return Ratios

Uflex

- Debt-to-equity: ~1.0–1.2x; leverage and finance cost are material. (bajajbroking.in)

- ROE: broadly mid-single digit (≈5–7% recent). ROCE similarly single digit (≈8–9%). (bajajbroking.in)

- Interest coverage is moderate and debt/EBITDA elevated, so balance sheet risk is non-trivial. (stockanalysis.com)

RDB Rasayans

- Debt-to-equity: effectively zero (debt-free; total debt / equity ~0.0x). (angelone.in)

- ROE: ~13–14%; ROCE ~18–19% (FY25). (angelone.in)

- Very high liquidity (current ratio well above 5x historically) and strong interest cover. (timesofindia.indiatimes.com)

Merit: On balance sheet strength and capital efficiency, RDB Rasayans is decisively better (debt-free, higher ROE/ROCE).

---

4. Valuation Snapshot (late Dec 2025 – indicative, not live)

(Ratios move with price; treat these as approximate)

- Uflex

- Mcap: ~₹3,400–3,500 crore.

- P/E (TTM): roughly high single-digit–low double-digit depending on source (~9–25x; variation due to normalised vs reported earnings). (angelone.in)

- P/B: deep discount to book, ~0.45–0.5x. (angelone.in)

- RDB Rasayans

- Mcap: ~₹300–320 crore. (angelone.in)

- P/E (TTM): around 8–10x. (angelone.in)

- P/B: ~1.0–1.4x (around book or small premium). (angelone.in)

Merit:

- Uflex is cheaper vs book value and trades at a discount to peers on P/B, reflecting leverage and weaker ROE.

- RDB trades around fair value or a mild premium to book but with higher ROE/ROCE and no debt.

---

5. Risk Considerations

Uflex – key risks/positives

- Positives: scale, global diversification, strong customer base (top FMCG brands), visible capex in recycling and films, FY25 profitability turnaround. (uflexltd.com)

- Risks: high leverage; cyclical packaging films margins; historical volatility in earnings; lower return ratios; some external research flags weak long-term profit CAGR and elevated debt/EBITDA. (bajajbroking.in)

RDB Rasayans – key risks/positives

- Positives: debt-free, strong margins and ROE, high liquidity, improving ROCE and profitability trend. (capitalmarket.com)

- Risks: micro-cap with single primary plant (concentration risk), lower liquidity in the stock, dependence on a narrow product line (FIBC/woven bags) and limited management bench compared to a large MNC. Some quarters show high share of non-operating income in PBT, which can raise questions on sustainability of current profit levels. (marketscreener.com)

---

6. Which looks better on “merits”?

Purely on financial quality (margins, ROE/ROCE, leverage) as of FY25:

- RDB Rasayans looks stronger:

- High and stable margins

- ROE/ROCE in mid-teens to high-teens

- Debt-free balance sheet

- Reasonable P/E, around book value

On business scale, diversification, and global franchise:

- Uflex is superior:

- Much larger revenue base

- Integrated across films, flexible packaging, chemicals, engineering

- Global customer relationships and export presence

On valuation vs quality:

- Uflex offers a deep discount to book and “turnaround” angle but with higher balance-sheet and earnings risk.

- RDB Rasayans offers better quality at a fair price but is a much smaller, more concentrated bet.

---

Practical interpretation (illustrative, not a recommendation)

- Example: A conservative investor focusing on debt-free, high-ROE small caps and comfortable with micro-cap liquidity risk might find RDB Rasayans fundamentally more attractive on current numbers.

- Example: An investor willing to take higher cyclicality and leverage risk for potential re-rating of a global packaging player might study Uflex as a turnaround/value candidate.

Any actual decision should factor in your risk tolerance, time horizon, portfolio size, and diversification; this comparison is not a buy/sell call on either stock.

If you have any further queries, please connect with us on 022-6290-10141 (Timings : 09.00 AM to 05.00 PM) or you can email us on info@cniinfoxchange.com